Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from skyepeptides.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| 5-Amino-1-methylquinolinium chloride (NNMCI) | 3 | — | — | — | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| GHK-cu / BPC-157 / TB-500 / KPV | KLOW26-80-002 | TrustPointe Analytics | — | LAL | — | View |
| KLOW Blend | KLOW26-80-003 | Janoshik Analytical | — | HM | 2026-05-14 | View |
| Tesamorelin | TESA26-20-004 | Janoshik Analytical | 99.23% |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| Adamax | 2 | 99.76% | — | — |
| AHK-Cu | 1 | 99.87% | — | — | — | — |
| AOD-9604 | 2 | 99.53% | — | — |
| ARA-290 | 2 | 99.67% | — | — |
| BPC-157 | 4 | 99.89% | — | — | — |
| BPC-157/ TB500 Blend | 3 | — | — | — | — |
| BPC-157/GHK-cu Blend | 2 | — | — | — | — |
| Cagrilintide | 2 | 99.67% | — | — |
| Cardiogen | 1 | 99.78% | — | — | — | — |
| Cartalax | 1 | 99.87% | — | — | — |
| CJC-1295 DAC | 3 | 99.53% | — | — | — |
| Dihexa | 1 | — | — | — | — | — | — |
| DSIP | 1 | 99.80% | — | — | — |
| Epithalon | 2 | 99.46% | — | — |
| FOXO4-DRI | 1 | 99.81% | — | — | — |
| GHK-Cu | 5 | 99.80% | — | — | — |
| GHK-cu / BPC-157 / TB-500 / KPV | 6 | — | — | — | — |
| Hexarelin | 1 | 99.48% | — | — | — | — |
| IGF-LR3 | 3 | 99.30% | — | — |
| Ipamorelin / CJC-1295 (mod GRF 1-29) blend | 1 | — | — | — | — | — | — |
| Ipamorelin Blend | 4 | 99.88% | — | — |
| Kisspeptin | 2 | 99.44% | — | — |
| KLOW Blend | 3 | — | — | — | — |
| KPV | 2 | 99.53% | — | — |
| KPV/ GHK-cu Blend | 2 | — | — | — | — |
| Livagen | 1 | 99.92% | — | — |
| LL-37 | 2 | 99.55% | — | — | — |
| Melanotan II | 2 | 99.76% | — | — |
| Melanotan-1 | 3 | 99.88% | — | — |
| MOTS-C | 4 | 99.36% | — | — |
| N-Acetyl Semax Amidate | 2 | 99.89% | — | — | — | — |
| NAD+ | 4 | — | — | — | — |
| P-21 | 1 | 99.68% | — | — | — |
| PE-22-28 | 2 | 99.52% | — | — | — |
| PEG-MGF with Trehalose | 1 | 99.89% | — | — |
| Pinealon | 2 | 99.75% | — | — |
| PT-141 | 2 | 99.90% | — | — |
| Retatrutide | 9 | 99.74% | — | — |
| Selank | 4 | 99.85% | — | — |
| Selank/Semax blend | 1 | — | — | — | — |
| Semaglutide | 7 | 99.24% | — |
| Sermorelin | 6 | 99.52% | — | — |
| SLU-PP-332 | 2 | — | — | — | — | — | — |
| Snap-8 | 2 | 99.86% | — | — | — |
| Survodutide | 2 | 99.77% | — | — | — |
| TB-500 | 4 | 99.56% | — |
| Tesamorelin | 11 | 99.39% | — | — |
| Tesamorelin/Ipamorelin/MGF/GHRP-2 Blend | 5 | — | — | — | — |
| Testagen | 1 | 99.81% | — | — |
| Thymagen | 2 | 99.97% | — | — | — |
| Thymosin Alpha 1 | 3 | 99.30% | — | — |
| Thymulin | 1 | 99.48% | — | — | — |
| Tirzepatide | 10 | 99.82% | — | — |
| VIP | 1 | 99.65% | — | — | — |
| 2026-05-11 |
| View |
| Tesamorelin | TESA26-10-002 | Janoshik Analytical | 99.24% | HM | 2026-05-11 | View |
| AOD-9604 | AOD26-06-002 | Janoshik Analytical | 99.75% | HM | 2026-05-11 | View |
| Ipamorelin Blend | CJCIPA26-10-002 | Janoshik Analytical | — | HM | 2026-05-07 | View |
| BPC-157/ TB500 Blend | BPTB26-20-001 | Janoshik Analytical | — | HM | 2026-05-05 | View |
| Thymosin Alpha 1 | TA126-10-001 | Janoshik Analytical | 99.57% | HM | 2026-05-04 | View |
| Retatrutide | RET26-24-003 | Janoshik Analytical | 99.85% | HM | 2026-05-04 | View |
| Retatrutide | RET26-12-004 | Janoshik Analytical | 99.97% | HM | 2026-05-04 | View |
| PT-141 | PT26-10-002 | Janoshik Analytical | 99.93% | HM | 2026-04-29 | View |
| Retatrutide | RET26-12-003 | Janoshik Analytical | 99.63% | HM | 2026-04-29 | View |
| Tirzepatide | TZ26-60-003 | Janoshik Analytical | 99.87% | HM | 2026-04-29 | View |
| Melanotan II | MT226-10-001 | Janoshik Analytical | 99.96% | HM | 2026-04-29 | View |
| BPC-157/ TB500 Blend | BPTB26-10-001 | Janoshik Analytical | — | LALHM | 2026-04-23 | View |
| Klow Blend | KLOW26-80-002 | Janoshik Analytical | — | HM | 2026-04-23 | View |
| KPV/ GHK-cu Blend | KGHK26-50-001 | Janoshik Analytical | — | — | 2026-04-21 | View |
| Semaglutide | NASMX26-30-001 | Janoshik Analytical | — | HM | 2026-04-21 | View |
| Selank/Semax blend | SKSX26-10-001 | Janoshik Analytical | — | HM | 2026-04-21 | View |
| TB-500 | TB26-20-001 | Janoshik Analytical | 99.86% | HM | 2026-04-15 | View |
| Retatrutide | RET26-12-002 | Janoshik Analytical | 99.90% | LALHM | 2026-04-15 | View |
| NAD+ | NAD26-1000-001 | Janoshik Analytical | — | HM | 2026-04-14 | View |
| Selank | SK26-10-001 | Janoshik Analytical | 99.90% | HM | 2026-04-13 | View |
| BPC-157/GHK-cu Blend | GN26-60-001 | Janoshik Analytical | — | HM | 2026-04-10 | View |
| Selank | Sk26-05-002 | Janoshik Analytical | 99.80% | HM | 2026-04-07 | View |
| Adamax | ADA26-10-001 | Janoshik Analytical | 99.83% | HM | 2026-04-07 | View |
| Tirzepatide | TZ26-30-002 | Janoshik Analytical | 99.91% | HM | 2026-04-07 | View |
| N-Acetyl Semax Amidate | NASMX26-30-001 | Janoshik Analytical | 99.90% | — | 2026-04-07 | View |
| KPV/ GHK-cu Blend | KGHK26-60-001 | Janoshik Analytical | — | LALHM | 2026-04-07 | View |
| Tirzepatide | TZ26-60-002 | Janoshik Analytical | 99.88% | HM | 2026-04-07 | View |
| Tesamorelin | TESA26-20-003 | Janoshik Analytical | 99.50% | LALHM | 2026-03-27 | View |
| Klow Blend | KLOW26-80-001 | Janoshik Analytical | — | HM | 2026-03-26 | View |
| Tesamorelin | TESA26-20-002 | Janoshik Analytical | 99.74% | LALHM | 2026-03-23 | View |
| GHK-Cu | GHKT26-1-001 | Janoshik Analytical | 99.80% | — | 2026-03-18 | View |
| PEG-MGF with Trehalose | PMG26-05-001 | Janoshik Analytical | 99.89% | HM | 2026-03-10 | View |
| Tesamorelin/Ipamorelin/MGF/GHRP-2 Blend | 4X26-13-001 | Janoshik Analytical | — | HM | 2026-03-09 | View |
| Ipamorelin | CJCIPA26-10-001 | Janoshik Analytical | — | LALHM | 2026-03-09 | View |
| 5-Amino-1-methylquinolinium chloride (NNMCI) | NAM26-50-001 | Janoshik Analytical | — | HM | 2026-03-09 | View |
| Livagen | LIV26-25-001 | Janoshik Analytical | 99.92% | HM | 2026-03-05 | View |
| Testagen | TGN26-50-001 | Janoshik Analytical | 99.81% | LALHM | 2026-03-05 | View |
| Kisspeptin | KIS26-10-001 | Janoshik Analytical | 99.34% | HM | 2026-03-05 | View |
| Retatrutide | RET26-24-002 | Janoshik Analytical | 99.83% | LALHM | 2026-03-05 | View |
| FOXO4-DRI | FOX26-15-001 | Janoshik Analytical | 99.81% | HM | 2026-03-03 | View |
| Ipamorelin / CJC-1295 (mod GRF 1-29) blend | CJCIPA26-10-001 | Janoshik Analytical | — | — | 2026-02-27 | View |
| Tesamorelin/Ipamorelin blend | 2X26-102-001 | Janoshik Analytical | — | HM | 2026-02-24 | View |
| IGF-LR3 | IGF26-01-001 | Janoshik Analytical | — | HM | 2026-02-20 | View |
| Tesamorelin 10mg/ Ipamorelin 5mg blend | 2X26-105-002 | Janoshik Analytical | — | LALHM | 2026-02-20 | View |
| Melanotan-1 | MT126-10-001 | Janoshik Analytical | 99.88% | HM | 2026-02-18 | View |
| Tesamorelin 10mg/ Ipamorelin 5mg blend | 2X26-105-001 | Janoshik Analytical | — | LALHM | 2026-02-13 | View |
| Tesamorelin | TESA26-20-001W | Janoshik Analytical | 99.53% | — | 2026-02-11 | View |
Disclosed Labs